Expanding the clinicopathological spectrum of late cutaneous Lyme borreliosis (acrodermatitis chronica atrophicans [ACA]): A prospective study of 20 culture- and/or polymerase chain reaction (PCR)-documented cases.
Fiche publication
Date publication
avril 2016
Journal
Journal of the American Academy of Dermatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CRIBIER Bernard, Dr GRANEL-BROCARD Florence, Pr LIPSKER Dan
Tous les auteurs :
Lenormand C, Jaulhac B, Debarbieux S, Dupin N, Granel-Brocard F, Adamski H, Barthel C, Cribier B, Lipsker D
Lien Pubmed
Résumé
The diagnosis of acrodermatitis chronica atrophicans (ACA), the late cutaneous manifestation of Lyme borreliosis, can be challenging. Histologic changes in ACA have been described in a few studies from endemic countries, relying on cases documented by serology only.
Mots clés
Acrodermatitis, diagnosis, Adult, Age Distribution, Aged, Aged, 80 and over, Biopsy, Needle, Borrelia burgdorferi, isolation & purification, Cohort Studies, DNA, Bacterial, analysis, Erythema Chronicum Migrans, diagnosis, Female, France, epidemiology, Humans, Immunohistochemistry, Incidence, Lyme Disease, diagnosis, Male, Middle Aged, Polymerase Chain Reaction, methods, Prognosis, Prospective Studies, Risk Assessment, Severity of Illness Index, Sex Distribution
Référence
J. Am. Acad. Dermatol.. 2016 Apr;74(4):685-92